Cardiol Therapeutics Stock Price

-0.10 (-5.32%)
Upgrade to Real-Time
Afterhours (Closed)
Volume 155,806
Bid Price 1.68
Ask Price 1.78
News -
Day High 1.85


52 Week Range


Day Low 1.73
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Cardiol Therapeutics Inc CRDL NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.10 -5.32% 1.78 20:00:01
Open Price Low Price High Price Close Price Prev Close
1.85 1.73 1.85 1.78 1.88
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
786 155,806 $ 1.78 $ 277,365 - 1.55 - 4.96
Last Trade Time Type Quantity Stock Price Currency
16:00:00 875 $ 1.78 USD


Draw Mode:

Cardiol Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 105.55M 59.30M 59.30M $ - $ - - -2.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - -

more financials information »

Cardiol Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical CRDL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.941.951.631.79364,291-0.16-8.25%
1 Month1.862.361.551.98558,644-0.08-4.3%
3 Months2.612.631.552.11578,131-0.83-31.8%
6 Months2.634.961.553.15750,968-0.85-32.32%
1 Year2.634.961.553.15750,968-0.85-32.32%
3 Years2.634.961.553.15750,968-0.85-32.32%
5 Years2.634.961.553.15750,968-0.85-32.32%

Cardiol Therapeutics Description

Cardiol Therapeutics Inc is a clinical-stage life sciences company developing therapies for cardiovascular disease (CVD). The lead product, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation being investigated in a Phase II/III study in hospitalized patients testing positive for COVID-19 with a prior history of, or risk factors for, CVD. The CardiolRx is also being investigated in patients with acute myocarditis, a leading cause of cardiac death in people less than 35 years old.
Your Recent History
Cardiol Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220129 13:25:22